A detailed history of Cws Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cws Financial Advisors, LLC holds 1,506 shares of AMGN stock, worth $396,650. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,506
Previous 1,506 -0.0%
Holding current value
$396,650
Previous $470,000 3.19%
% of portfolio
0.17%
Previous 0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$262.75 - $319.31 $4,204 - $5,108
-16 Reduced 1.05%
1,506 $470,000
Q1 2024

May 01, 2024

SELL
$268.87 - $324.56 $9,410 - $11,359
-35 Reduced 2.25%
1,522 $432,000
Q4 2023

Feb 08, 2024

SELL
$255.7 - $288.46 $5,114 - $5,769
-20 Reduced 1.27%
1,557 $448,000
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $7,871 - $9,772
36 Added 2.34%
1,577 $423,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $1,714 - $2,026
-8 Reduced 0.52%
1,541 $342,000
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $14,224 - $17,337
63 Added 4.24%
1,549 $374,000
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $13,512 - $17,169
-59 Reduced 3.82%
1,486 $390,000
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $1,571 - $1,772
7 Added 0.46%
1,545 $348,000
Q1 2022

May 03, 2022

BUY
$219.27 - $242.57 $11,182 - $12,371
51 Added 3.43%
1,538 $372,000
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $198 - $227
1 Added 0.07%
1,487 $335,000
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $221 - $258
1 Added 0.07%
1,486 $370,000
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $234 - $260
1 Added 0.07%
1,485 $377,000
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $17,209 - $21,118
-87 Reduced 5.54%
1,484 $350,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $297,248 - $382,067
1,571 New
1,571 $379,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cws Financial Advisors, LLC Portfolio

Follow Cws Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cws Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cws Financial Advisors, LLC with notifications on news.